Your Health, We Care
Lenacapavir, in combination with other antiretroviral drugs, is indicated for the treatment of heavily treated adult HIV-1-infected patients with multidrug resistance whose current antiretroviral treatment regimens have failed due to drug resistance, intolerance, or safety considerations.
FDA，2024.11
In combination with other antiretroviral drugs, it is indicated for the treatmen···【more】
Release date：2026-01-05Recommended：3
